124 related articles for article (PubMed ID: 7250205)
1. AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart.
Kobinger W; Lillie C
Eur J Pharmacol; 1981 Jun; 72(2-3):153-64. PubMed ID: 7250205
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
Kobinger W; Lillie C
Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular actions of 5,6-dimethoxy-2-(3-[(alpha-(3,4-dimethoxy) phenylethyl)-methylamino] propyl) phthalimidine (AQ-A 39), a specific bradycardic agent.
Dämmgen J; Kadatz R; Diederen W
Arzneimittelforschung; 1981; 31(4):666-70. PubMed ID: 7195712
[TBL] [Abstract][Full Text] [Related]
4. Effects of a specific bradycardic agent (AQ-A39) and verapamil on beta-adrenergic responses in isolated guinea pig atria.
Siegl PK; Morgan G
Can J Physiol Pharmacol; 1987 Feb; 65(2):146-51. PubMed ID: 3032382
[TBL] [Abstract][Full Text] [Related]
5. Actions of alinidine and AQ-A 39 on rate and contractility of guinea pig atria during beta-adrenoceptor stimulation.
Lillie C; Kobinger W
J Cardiovasc Pharmacol; 1983; 5(6):1048-51. PubMed ID: 6196553
[TBL] [Abstract][Full Text] [Related]
6. Bradycardic effects of AQ-A 39 (falipamil) in situ and in isolated, blood-perfused dog hearts. Comparison with alinidine and verapamil.
Ogiwara Y; Furukawa Y; Akahane K; Haniuda M; Chiba S
Jpn Heart J; 1988 Nov; 29(6):849-61. PubMed ID: 3241338
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of two specific bradycardic agents AQ-A39 (falipamil) and AQ-AH 208 on reversible myocardial reperfusion damage in anesthetized dogs.
Gross GJ; Daemmgen JW
J Pharmacol Exp Ther; 1986 Aug; 238(2):422-8. PubMed ID: 3735124
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular responses to increasing plasma concentrations of AQ-A 39 Cl, a new compound with negative chronotropic effects.
Verdouw PD; Bom HP; Bijleveld RE
Arzneimittelforschung; 1983; 33(5):702-6. PubMed ID: 6683548
[TBL] [Abstract][Full Text] [Related]
9. [The action of a new calcium antagonist 5,6-dimethoxy-2-(3 [(alpha-(3,4-dimethoxy)-phenylethyl)methylamino] propyl)-phthalimidine hydrochloride (AQ-A 39cl) on hemodynamics and ischemia parameters in exercise ECG of patients with coronary heart disease].
Jost S; Schulz W; Kober G
Arzneimittelforschung; 1985; 35(8):1279-82. PubMed ID: 4074444
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological studies on effects of AQ-A 39 in the isolated guinea pig heart and myocardial preparations.
Hohnloser S; Weirich J; Homburger H; Antoni H
Arzneimittelforschung; 1982; 32(7):730-4. PubMed ID: 6889873
[TBL] [Abstract][Full Text] [Related]
11. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
Kawada M; Satoh K; Taira N
J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
[TBL] [Abstract][Full Text] [Related]
12. AQ-AH 208, a new bradycardic agent, increases coronary collateral blood flow to ischemic myocardium.
Daemmgen JW; Gross GJ
J Cardiovasc Pharmacol; 1985; 7(6):1048-54. PubMed ID: 2418287
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cardiovascular responses to the bradycardic drugs, alinidine, AQ-A 39, and mixidine, in the anesthetized dog.
Siegl PK; Wenger HC; Sweet CS
J Cardiovasc Pharmacol; 1984; 6(4):565-74. PubMed ID: 6206308
[TBL] [Abstract][Full Text] [Related]
14. Effect of the new specific bradycardia agent AQ-A39 (falipamil) on coronary collateral blood flow in dogs.
Gross GJ; Daemmgen JW
J Cardiovasc Pharmacol; 1987 Jul; 10(1):123-7. PubMed ID: 2441148
[TBL] [Abstract][Full Text] [Related]
15. Investigations into the bradycardic effects of UL-FS 49 (1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on-hydrochloride) in isolated guinea pig atria.
Lillie C; Kobinger W
J Cardiovasc Pharmacol; 1986; 8(4):791-7. PubMed ID: 2427820
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the bradycardic effects of alinidine (St 567), AQ-A 39 and verapamil on guinea-pig sinoatrial node superfused with different Ca2+ and NaCl solutions.
Lillie C; Kobinger W
Eur J Pharmacol; 1983 Jan; 87(1):25-33. PubMed ID: 6840187
[TBL] [Abstract][Full Text] [Related]
17. Decrease in bradycardic effect of AQ-A 39 and alinidine in guinea-pig sinoatrial node depolarized by high external K+-concentration.
Lillie C; Kobinger W
Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):210-3. PubMed ID: 6527706
[TBL] [Abstract][Full Text] [Related]
18. Effects of AQ-AH 208, a new specific bradycardic agent, on myocardial ischemia-reperfusion injury in anesthetized dogs.
Gross GJ; Warltier DC; Daemmgen JW
J Cardiovasc Pharmacol; 1985; 7(5):929-36. PubMed ID: 2413303
[TBL] [Abstract][Full Text] [Related]
19. Investigations into the bradycardic action of indoramin.
Lillie C; Harron DW; Kobinger W
Arzneimittelforschung; 1985; 35(1A):301-5. PubMed ID: 4039170
[TBL] [Abstract][Full Text] [Related]
20. Binding of two specific bradycardic agents, alinidine and AQ-A 39, to muscarinic receptors of guinea pig atria and ventricle.
Brunner F; Kukovetz WR
J Cardiovasc Pharmacol; 1988 Feb; 11(2):222-9. PubMed ID: 2452318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
